HØRSHOLM, Denmark--(BUSINESS WIRE)--In accordance with Section 29 of the Securities Trading Act LifeCycle Pharma A/S (OMX: LCP) today announced that LCP has received a notification from ATP and ATP Invest that it after purchase has shareholdings in LCP of 2,873,215 shares of nom. DKK 1, corresponding to 5.09% of the share capital and the voting rights in LCP.
